Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Second interim dividend

27 Jun 2025 17:57

RNS Number : 8462O
Experian plc
27 June 2025
 

Experian plc

 

 

Second interim dividend - exchange rate and Irish dividend withholding tax

 

 

27 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that, further to the announcement on 14 May 2025 of a second interim dividend of 43.25 US cents per ordinary share payable on 18 July 2025 to shareholders on the register of members at the close of business on 20 June 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 20 June 2025 to receive payment in US dollars, will be £1 = $1.37168. Accordingly, the sterling amount of dividend payable on 18 July 2025 to such shareholders will be approximately 31.5306 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 20 June 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQDLFLEQLEBBQ
Date   Source Headline
16th Oct 20195:13 pmRNSTransaction in Own Shares
15th Oct 20195:13 pmRNSTransaction in Own Shares
14th Oct 20194:48 pmRNSTransaction in Own Shares
11th Oct 20194:55 pmRNSTransaction in Own Shares
7th Oct 201910:58 amRNSShare repurchase programme
4th Oct 20195:05 pmRNSTransaction in Own Shares
3rd Oct 20195:13 pmRNSTransaction in Own Shares
2nd Oct 20195:17 pmRNSTransaction in Own Shares
2nd Oct 20199:15 amRNSAdditional Listing
30th Sep 201912:26 pmRNSTotal Voting Rights
25th Sep 20195:10 pmRNSTransaction in Own Shares
20th Sep 20195:09 pmRNSTransaction in Own Shares
19th Sep 20194:55 pmRNSTransaction in Own Shares
19th Sep 201912:54 pmRNSBlock listing Interim Review
18th Sep 20194:52 pmRNSTransaction in Own Shares
17th Sep 20194:57 pmRNSTransaction in Own Shares
16th Sep 20195:03 pmRNSTransaction in Own Shares
13th Sep 20195:01 pmRNSTransaction in Own Shares
12th Sep 20195:20 pmRNSTransaction in Own Shares
11th Sep 20195:09 pmRNSTransaction in Own Shares
10th Sep 20195:10 pmRNSTransaction in Own Shares
30th Aug 201911:58 amRNSTotal Voting Rights
22nd Aug 20199:37 amRNSAdditional Listing
21st Aug 20198:00 amRNSExperian acquires Look Who's Charging
15th Aug 20195:09 pmRNSTransaction in Own Shares
8th Aug 201911:00 amRNSAcquisition of MyHealthDirect
6th Aug 20195:05 pmRNSTransaction in Own Shares
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.